Key Points Hims & Hers has launched Hers in Australia, expanding its women’s health services across hair regrowth, menopause, perimenopause and weight management. The launch…
FiscalNote Holdings Inc. (OTC: NOTE) shares climbed 20.42% today by mid-day. Trading volume reached 403,952 shares, approaching its average daily volume of approximately 509,067 shares…
October 13 is Metastatic Breast Cancer Awareness Day, which spotlights the stage of breast cancer that still has no cure and the emerging companies working…
Lipocine Inc. (NASDAQ: LPCN), a specialty pharmaceutical company developing oral therapeutics, announced on October 7, 2026 that Health Canada has approved TLANDO (testosterone undecanoate) capsules…
PDS Biotechnology Corporation (NASDAQ: PDSB) shares surged 43.62% to $1.07 as of 12:05 p.m. ET Monday, gaining $0.33 from Friday’s $0.75 close. The stock traded…
September 24, 2026
Nuvectis’ NXP200 Receives China Breakthrough Therapy Designation for BRAF V600-Mutant High-Grade Glioma
Key Points Nuvectis Pharma said China’s Center for Drug Evaluation granted Breakthrough Therapy Designation to NXP200 for recurrent or progressive BRAF V600-mutant high-grade glioma. NXP200,…
PDS Biotechnology Corporation (NASDAQ: PDSB) is up 46.65% at $0.5853 in the latest regular session, after trading between $0.41 and $0.76. The sharp advance followed…
PDS Biotechnology Corporation (NASDAQ: PDSB) shares surged 86.47% Tuesday to $0.7442, up $0.3451 from the prior close of $0.3991. The stock opened at $0.4918 and…
September 08, 2026
PRISM Mid-Day Movers: Women’s Health and New Energy are Today’s Leaders.
PDS Biotechnology (NASDAQ: PDSB) is trading at 0.2894, up 31.55% from Friday’s 0.22 close. After opening at 0.4894 and rallying to 0.651, shares reversed sharply…
INVO Fertility (IVF) is soaring today, up 107.90% to 2.02 from Friday’s 0.9716 close, though it has pulled back from an intraday high of 2.80…
August 17, 2026
Femasys Bolsters Its Growth Plan With $30 Million Financing as FemBloc and FemaSeed Programs Advance
Key Points Femasys completed a $30 million private placement after June 30, with up to $60 million in potential additional proceeds if related warrants are…
August 04, 2026
DarioHealth Expands Its Provider-Backed Cardiometabolic Platform with New Women’s Health and Sleep Programs
Key Points DarioHealth Corp. is broadening its digital cardiometabolic platform with new women’s health and sleep-focused services. The company is adding provider-backed care and clinical…